According to the results of our study, although aspirin use reduced macrophage, CD4 + T-lymphocyte, and CD8 + T-lymphocytes amount in the ACS + P group, it did not clinically affect periodontal disease severity (similar to BOP) and CD4 + / CD8 + ratio. The gene discussed is CD8A; the disease is periodontal disorder.